- Home
- NRXS vs CDIO Comparison
NRXS vs CDIO Comparison
Compare NRXS & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXS
- CDIO
- Stock Information
- Founded
- NRXS 2011
- CDIO 2017
- Country
- NRXS United States
- CDIO United States
- Employees
- NRXS N/A
- CDIO N/A
- Industry
- NRXS
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- NRXS
- CDIO Health Care
- Exchange
- NRXS Nasdaq
- CDIO Nasdaq
- Market Cap
- NRXS 17.8M
- CDIO 20.2M
- IPO Year
- NRXS 2023
- CDIO N/A
- Fundamental
- Price
- NRXS $2.31
- CDIO $0.50
- Analyst Decision
- NRXS
- CDIO Buy
- Analyst Count
- NRXS 0
- CDIO 1
- Target Price
- NRXS N/A
- CDIO $2.00
- AVG Volume (30 Days)
- NRXS 22.4K
- CDIO 2.5M
- Earning Date
- NRXS 04-08-2025
- CDIO 03-31-2025
- Dividend Yield
- NRXS N/A
- CDIO N/A
- EPS Growth
- NRXS N/A
- CDIO N/A
- EPS
- NRXS N/A
- CDIO N/A
- Revenue
- NRXS $2,456,219.00
- CDIO $35,688.00
- Revenue This Year
- NRXS $383.16
- CDIO $228.74
- Revenue Next Year
- NRXS N/A
- CDIO $854.55
- P/E Ratio
- NRXS N/A
- CDIO N/A
- Revenue Growth
- NRXS N/A
- CDIO 180.90
- 52 Week Low
- NRXS $2.05
- CDIO $0.19
- 52 Week High
- NRXS $3.78
- CDIO $1.86
- Technical
- Relative Strength Index (RSI)
- NRXS 38.24
- CDIO 45.05
- Support Level
- NRXS $2.39
- CDIO $0.47
- Resistance Level
- NRXS $2.51
- CDIO $0.69
- Average True Range (ATR)
- NRXS 0.15
- CDIO 0.08
- MACD
- NRXS -0.03
- CDIO 0.01
- Stochastic Oscillator
- NRXS 7.14
- CDIO 33.88
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.